Literature DB >> 24906855

Generation of a biomimetic human artificial cornea model using Wharton's jelly mesenchymal stem cells.

Ingrid Garzón1, Miguel Angel Martín-Piedra1, Camilo Alfonso-Rodríguez1, Miguel González-Andrades2, Victor Carriel1, Carlos Martínez-Gómez3, Antonio Campos1, Miguel Alaminos1.   

Abstract

PURPOSE: Human Wharton's jelly stem cells (HWJSCs) are able to differentiate into skin and oral mucosa epithelial-like cells. In this work, we demonstrate for the first time the capability of HWJSCs to differentiate in vitro into cornea epithelial-like cells in a three-dimensional model.
METHODS: First, primary cell cultures of HWJSCs, corneal epithelial cells, and corneal keratocytes were cultured and three-dimensional orthotypic and heterotypic human cornea models were generated with fibrin-agarose scaffolds. Then, in vitro differentiation of HWJSCs and corneal epithelial cells was performed with keratinocytic inductive medium in a three-dimensional system that allowed interaction between stromal and epithelial compartments. Histological, histochemical, and immunofluorescence analyses were used to determine the differentiation status of each sample.
RESULTS: Our results demonstrated that HWJSCs were able to differentiate into corneal epithelial-like cells, with results similar to the native cornea. Heterotypical corneas generated with HWJSCs showed adequate differentiation of the epithelium and stroma, and were similar to orthotypic and native corneas in the expression of epithelial markers (CK3/12, PKG, ZO1, and CX43) and extracellular matrix components (proteoglycans, collagen, elastic and reticular fibers). Immunofluorescence analysis confirmed the presence of crystallins Cry-αA, Cry-αB, Cry-β, and Cry-ζ with moderate or weak expression of Cry-βγ3 and Cry-λ1 (key proteins involved in cornea transparency) in both models.
CONCLUSIONS: Our findings suggest that HWJSCs can be considered an alternative cell source for cornea regeneration and may offer a solution for patients with limbus stem cell deficiency. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.

Entities:  

Keywords:  cornea; corneal epithelial-like cells; human umbilical cord Wharton's jelly cells; tissue engineering; transdifferentiation

Mesh:

Year:  2014        PMID: 24906855     DOI: 10.1167/iovs.14-14304

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  22 in total

Review 1.  Stem Cells in the Cornea.

Authors:  Andrew J Hertsenberg; James L Funderburgh
Journal:  Prog Mol Biol Transl Sci       Date:  2015-05-27       Impact factor: 3.622

2.  Wharton's jelly-derived mesenchymal cells as a new source for the generation of microtissues for tissue engineering applications.

Authors:  D Durand-Herrera; F Campos; B D Jaimes-Parra; J D Sánchez-López; R Fernández-Valadés; M Alaminos; A Campos; V Carriel
Journal:  Histochem Cell Biol       Date:  2018-06-11       Impact factor: 4.304

3.  Encapsulation of human elastic cartilage-derived chondrocytes in nanostructured fibrin-agarose hydrogels.

Authors:  Laura García-Martínez; Fernando Campos; Carlos Godoy-Guzmán; María Del Carmen Sánchez-Quevedo; Ingrid Garzón; Miguel Alaminos; Antonio Campos; Víctor Carriel
Journal:  Histochem Cell Biol       Date:  2016-09-01       Impact factor: 4.304

Review 4.  Engineering epithelial-stromal interactions in vitro for toxicology assessment.

Authors:  David G Belair; Barbara D Abbott
Journal:  Toxicology       Date:  2017-03-08       Impact factor: 4.221

5.  Development of secretome-based strategies to improve cell culture protocols in tissue engineering.

Authors:  O Cases-Perera; C Blanco-Elices; J Chato-Astrain; C Miranda-Fernández; F Campos; P V Crespo; I Sánchez-Montesinos; M Alaminos; M A Martín-Piedra; I Garzón
Journal:  Sci Rep       Date:  2022-06-15       Impact factor: 4.996

Review 6.  Limbal Stem Cell Deficiency: Current Treatment Options and Emerging Therapies.

Authors:  Michel Haagdorens; Sara Ilse Van Acker; Veerle Van Gerwen; Sorcha Ní Dhubhghaill; Carina Koppen; Marie-José Tassignon; Nadia Zakaria
Journal:  Stem Cells Int       Date:  2015-12-14       Impact factor: 5.443

7.  Differentiation of human umbilical cord Wharton's jelly-derived mesenchymal stem cells into endometrial cells.

Authors:  Qin Shi; JingWei Gao; Yao Jiang; Baolan Sun; Wei Lu; Min Su; Yunzhao Xu; Xiaoqing Yang; Yuquan Zhang
Journal:  Stem Cell Res Ther       Date:  2017-11-02       Impact factor: 6.832

Review 8.  The promise of stem cell-based therapeutics in ophthalmology.

Authors:  Israel Aharony; Shalom Michowiz; Nitza Goldenberg-Cohen
Journal:  Neural Regen Res       Date:  2017-02       Impact factor: 5.135

9.  Biofabrication of a Tubular Model of Human Urothelial Mucosa Using Human Wharton Jelly Mesenchymal Stromal Cells.

Authors:  Ingrid Garzón; Boris Damián Jaimes-Parra; Manrique Pascual-Geler; José Manuel Cózar; María Del Carmen Sánchez-Quevedo; María Auxiliadora Mosquera-Pacheco; Indalecio Sánchez-Montesinos; Ricardo Fernández-Valadés; Fernando Campos; Miguel Alaminos
Journal:  Polymers (Basel)       Date:  2021-05-13       Impact factor: 4.329

10.  Human Umbilical Cord-Derived Mesenchymal Stem Cells Promote Corneal Epithelial Repair In Vitro.

Authors:  Santhosh Kacham; Tejal Sunil Bhure; Sindhuja D Eswaramoorthy; Gaurav Naik; Subha Narayan Rath; Sreenivasa Rao Parcha; Sayan Basu; Virender Singh Sangwan; Sachin Shukla
Journal:  Cells       Date:  2021-05-19       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.